Adenocarcinoma of Esophagogastric Junction

16 clinical trials · Condition

Record	Firm	Date
A Modified Esophagogastric Reconstruction Method After Laparoscopic Proximal Gastrectomy (NCT05829213)	Peking University	2021-11-01
TQB2450 Plus Anlotinib Combined With Chemotherapy in the Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma (NCT04891900)	Henan Cancer Hospital	2021-05-10
Pembrolizumab Plus Neoadjuvant Chemotherapy for Locally Advanced EGJ Adenocarcinoma (NCT04813523)	Tianjin Medical University Cancer Institute and Hospital	2021-04-01
Transhiatal/Transabdominal Approach Compare With Thoracoabdominal Approach for Siewert II Adenocarcinoma of Esophagogastric Junction (NCT04910789)	Chinese PLA General Hospital	2019-12-11
A Phase 1 Study of ZSP1602 in Participants With Advanced Solid Tumors (NCT03734913)	Guangdong Zhongsheng Pharmaceutical Co., Ltd.	2019-01-25
Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors (NCT03302403)	Kang YU	2017-12-29
Impact on Quality of Life in Patients Undergoing Total Gastrectomy or Proximal Gastrectomy for Adenocarcinoma of Esophagogastric Junction (NCT01697917)	Fudan University	2012-05-01
Tesetaxel as Second-line Therapy for Patients With Advanced Gastric Cancer (NCT01095120)	Genta Incorporated	2010-03-01

Every clearance here is in the API, with alerts when new ones post.